Psyched Wellness Submits Trademark For Amanita Muscaria Extract

Psyched Wellness (CSE: PSYC) is looking to build up its portfolio of intellectual property. The company this morning announced that it has submitted an application to register a trademark for the unique extraction process that it has developed.

The company is looking to register the trademark “AME-1”, which stands for Amanita Muscaria Extract-1. The trademark is related to the unique extract that the company developed after a long process of trial and error, resulting in the creation of the ideal extract for future products.

More specifically, Psyched Wellness this morning outlined that it was able to finalize the extraction process after it developed a high performance liquid chromatography analytical method for the unique compounds and raw material within Amanita Muscaria. As a result, AME-1 is to be the base for future product lines created in the health and wellness space.

Going forward, the company intends to build a patent portfolio around AME-1 for optimized psychedelic medicines.

Psyched Wellness last traded at $0.35 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Tudor Gold x American Creek: Consolidating A Massive Gold Project

Aura Minerals: The Era Dorada Underground PEA

Gold Is Now Smart Money’s End Game | Doug Casey

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Psyched Wellness Completes 14 Day Oral Toxicity Preclinical Study For Proprietary Extract

Psyched Wellness (CSE: PSYC) this morning announced the results of its initial 14-day oral toxicity...

Tuesday, July 6, 2021, 08:58:10 AM

Psyched Wellness Commences 90-Day Toxicity Study Of AME-1

Psyched Wellness (CSE: PSYC) continues to progress on its preclinical studies for its novel mushroom...

Monday, June 28, 2021, 08:55:03 AM

Psyched Wellness Latest Firm To Conduct Bought Deal Financing

Psyched Wellness (CSE: PSYC) is the latest psychedelics-focused firm to announce a bought deal financing,...

Thursday, January 21, 2021, 07:53:05 PM

Psyched Wellness To Conduct Stability Tests On Proprietary Mushroom Extract

Psyched Wellness (CSE: PSYC) is progressing with the development of its flagship product, an extract...

Monday, July 26, 2021, 09:28:00 AM

Psyched Wellness To Commence Trading Today

Psyched Wellness (CSE: PSYC) is the latest mushroom issue to hit the CSE, with the...

Thursday, October 22, 2020, 08:36:53 AM